Navigation Links
Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
Date:2/9/2011

able differences in non-ocular adverse events among the study arms.

Trials in other indications such as CRVO and DME are currently underway or in preparation.

About Wet Age-Related Macular Degeneration (wet AMD)Age-related macular degeneration (AMD) is a leading cause of acquired blindness.  Macular degeneration is diagnosed as either dry (non-exudative) or wet (exudative).  In wet AMD, new blood vessels grow beneath the retina and leak blood and fluid.  This leakage causes disruption and dysfunction of the retina creating distortion and/or blind spots in central vision, and it can account for blindness in wet AMD patients.  Wet AMD is the leading cause of blindness for people over the age of 65 in the U.S. and Europe.  It is estimated that more than 210,000 Americans are newly diagnosed with and treated for wet AMD each year.

About Central Retinal Vein Occlusion (CRVO)Over 100,000 people in the United States and more than 66,000 people in key European countries are estimated to suffer from central retinal vein occlusion (CRVO).  CRVO is caused by obstruction of the central retinal vein that leads to a back up of blood and fluid in the retina.  This causes retinal injury and loss of vision.  The retina can also become "ischemic" (starved for oxygen), resulting in the growth of new, inappropriate blood vessels that can cause further vision loss and more serious complications.  Release of vascular endothelial growth factor (VEGF) contributes to increased vascular permeability in the eye and inappropriate new vessel growth.  It is believed that anti-VEGF treatment may help decrease vascular permeability and edema and prevent the inappropriate growth of new blood vessels in the retina in patients with CRVO.

About Diabetic Macular Edema (DME)Diabetic macular edema (DME) is the most prevalent cause of moderate vision loss in patients with diabetes.  DME is a common complica
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regeneron Announces Presentation at the ISI Annual Conference
2. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
3. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
4. Christine A. Poon Elected to Regeneron Board of Directors
5. Regeneron Announces Presentation at the 2010 Credit Suisse Annual Healthcare Conference
6. Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference
7. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
8. Regeneron Increases Size of Public Offering of Common Stock
9. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
10. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
11. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Va. , July 28, 2014  Serco ... services, announced the Company has been awarded a ... Support Command (NEMSCOM) and its Deployable Medical Systems.  ... enable medical personnel to provide world-class healthcare to ... operating environment across the globe. The five year ...
(Date:7/28/2014)... Ala. , July 28, 2014 ... J. Tipton , Ph.D., President and CEO of ... the Controlled Release Society (CRS) for the 2014-2015 ... annual meeting on July 12 in ... 40 countries.  The Controlled Release ...
(Date:7/28/2014)... Texas , July 28, 2014  MedSpring Urgent Care, an ... walk-in clinic at 517 S. Lamar Blvd., Austin, TX ... care clinic is located on the southeast corner of Barton ... on-site from 9 a.m. - 9 p.m. daily, including weekends and ... of Texas, Central Austin , Anderson Mill ...
Breaking Medicine Technology:Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2
... May Offer Long-Lasting ... OLDSMAR, Fla., Aug. 25 Time. It is a precious,commodity. ... enough,of it. And the small amount of time a woman spends ... time she invests in others.,This reality has led many women in ...
... Front Line CLL, NHL and CLL Retreatment and Japanese Development Studies ... ... Genmab has,announced plans to begin four studies of ofatumumab in chronic ... to begin four studies of,ofatumumab in chronic lymphocytic leukemia (CLL) and follicular,non-Hodgkin,s ...
Cached Medicine Technology:Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4
(Date:7/28/2014)... 2014 The report, “Blowing Agents ... - Trends and Forecasts to 2019” defines and ... and forecasting of the global consumption volume and ... tables with 39 figures spread through 226 Pages ... http://www.marketsandmarkets.com/Market-Reports/blowing-agents-market-71329121.html , Blowing agents are highly utilized ...
(Date:7/28/2014)... NJ (PRWEB) July 28, 2014 ... representing the majority of professionals engaged in the ... of the Transplantation and Immunology Research Network ... transplantation and immunology research. As modern organ transplantation ... a network that could provide more opportunities for ...
(Date:7/28/2014)... treatment for patients with one of the UK,s most ... , Chronic obstructive pulmonary disease (COPD) is the name ... due to long-term damage to the lungs. Often ... cent of all hospital admissions in the UK, with ... after they are discharged. , A team ...
(Date:7/28/2014)... 2014 With California in a record ... news that a fire blanket that is ... under development by SunSeeker Enterprises, Inc. The fire blanket—utilizing ... from the extreme heat of re-entry into the Earth's ... homes. , “Our firefighters routinely lay their very lives ...
(Date:7/28/2014)... Windsor, Co (PRWEB) July 28, 2014 ... Colorado has unveiled new plans to raise investment capital ... growing 24/7 fitness concept in the United States. , ... increasing popularity of 24/7 fitness centers provide a great ... into this rapidly expanding space. In addition to this, ...
Breaking Medicine News(10 mins):Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 2Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 3Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2
... CFO and Interim CEO of Everyday Wireless to ... A Place for Mom,( http://www.aplaceformom.com/ ) announced today ... of Finance. Longstreth will oversee,the financial performance of ... strategy, as well as evaluate new business,opportunities to ...
... 24 Karen Ignagni, President,and CEO of America,s ... in response to the U.S. House of Representatives,passage ... legislation that would require Medicare,Advantage beneficiaries to pay ... impact these cuts would have on vulnerable seniors.,As ...
... 24 LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider ... announces the resignation of Executive Vice President,of Finance ... J.,Celebrezze has been named interim Chief Financial Officer, ... 2007, Mr. Celebrezze has served on the,Executive Management ...
... sicker patients may be getting bare metal devices, study ... patients who got drug-coated stents did better than those ... study found. , But it isn,t a simple either-or ... the experience of almost 39,000 Medicare recipients who underwent ...
... In lab setting, they caused some machines to turn ... (HealthDay News) -- Those magic little devices that allow ... toll electronically could interfere with the operation of critical ... laboratory setting not involving actual patients, Dutch scientists found ...
... agents could have unforeseen risks in individuals with heart ... in St. Louis. The anticancer drugs which go ... with a biochemical process that promotes growth in some ... this biochemical process in mice with heart disease led ...
Cached Medicine News:Health News:A Place for Mom, Nation's Largest Assisted Living and Senior Housing Referral Service Announces New Vice President of Finance 2Health News:AHIP Statement on House Passage of H.R. 6331 2Health News:LCA-Vision Announces CFO Change 2Health News:Drug-Coated Stents Reduce Repeat Artery Procedures 2Health News:Drug-Coated Stents Reduce Repeat Artery Procedures 3Health News:Radio-Wave Devices May Play Havoc With Medical Equipment 2Health News:Radio-Wave Devices May Play Havoc With Medical Equipment 3Health News:Certain anti-cancer agents could be harmful to patients with heart disease 2Health News:Certain anti-cancer agents could be harmful to patients with heart disease 3
Inquire...
... (Low Melt), A low temperature agarose ... temperature , Optimal for in-gel restriction digestion/ligation ... a very manageable clear gel that provides ... at approximately 65°C and remains fluid at ...
... UltraClean Agarose, Molecular Biology ... electrophoretic separation of nucleic acids. ... isolate DNA fragments from 0.2 ... of UltraClean Agarose is tested ...
... Agarose 1000 is specifically formulated for high ... fragments <1000 bp. This standard melting temperature ... little as 10 bp difference in size. ... strong gel structure for better handling and ...
Medicine Products: